Focused Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Focused Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30	Closed	-$836	–	1028
2023 Q3	$836	Hold	30	–	–	﹤0.01%	864
2023 Q2	$1.02K	Hold	30	–	–	﹤0.01%	881
2023 Q1	$902	Buy	+30	New	+$930	﹤0.01%	883
2022 Q4	–	Sell	-31	Closed	-$1K	–	1093
2022 Q3	$1K	Hold	31	–	–	﹤0.01%	809
2022 Q2	$1K	Hold	31	–	–	﹤0.01%	790
2022 Q1	$1K	Hold	31	–	–	﹤0.01%	847
2021 Q4	$2K	Hold	31	–	–	﹤0.01%	788
2021 Q3	$2K	Hold	31	–	–	﹤0.01%	796
2021 Q2	$3K	Hold	31	–	–	﹤0.01%	776
2021 Q1	$3K	Buy	+31	New	+$3.08K	﹤0.01%	767

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Focused Wealth Management's ARKG Position: Q4 2023 in Review

Focused Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 30 shares — an estimated $836 sold.

Focused Wealth Management first reported a position in ARKG in Q1 2021 and held it in 10 quarters. The position peaked at $3K in Q2 2021. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

Focused Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
Focused Wealth Management sold 30 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $836.
Focused Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 10 quarters.
Focused Wealth Management's ARK Genomic Revolution ETF position peaked at $3K in Q2 2021.
298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Focused Wealth Management's 13F filing for Q4 2023, filed 10 Jan 2024.